cGKI (cGMP-dependent protein kinase type I), also known as PRKG1, lowers the intracellular level of calcium and is important for the relaxation of vascular smooth muscle. cGKI beta Inhibitors offered by Santa Cruz inhibit cGKI beta and, in some cases, other intracellular cGMP and phosphorylation related proteins. View detailed cGKI beta Inhibitor specifications, including cGKI beta Inhibitor CAS number, molecular weight, molecular formula and chemical structure, by clicking on the product name.
indicates a highly recommended product based on customer preference.
|PRODUCT NAME/Application||CAS||Catalog #||QUANTITY||Price||Citations||RATING|
|Rp-8-Br-PET-cyclic GMPS, Sodium Salt is a competitive inhibitor of cGMP-dependent protein kinase (cGKI)||172806-20-1||
|(D) DT-2 is A potent, cell permeable and highly selective polypeptide inhibitor of cGMP dependent protein kinase 1α||
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2021 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.